Article info

Download PDFPDF

566 ATOR-1017, a second generation 4–1BB antibody with potential to enhance efficacy of PD-1 therapies
Free

Authors

Citation

Smith KE, Nilsson A, Ellmark P
566 ATOR-1017, a second generation 4–1BB antibody with potential to enhance efficacy of PD-1 therapies

Publication history

  • First published November 10, 2021.
Online issue publication 
March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.